BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12974118)

  • 1. Good news and bad news: the cost of mending a broken heart.
    Williams D
    Med Device Technol; 2003; 14(1):8-10. PubMed ID: 12974118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure.
    Technol Eval Cent Assess Program Exec Summ; 2004 Apr; 19(2):1. PubMed ID: 15314825
    [No Abstract]   [Full Text] [Related]  

  • 3. Special report: left ventricular assist devices as destination therapy for end-stage heart failure--cost-effectiveness analysis.
    TEC Bull (Online); 2003 Nov; 20(3):33-4. PubMed ID: 15043081
    [No Abstract]   [Full Text] [Related]  

  • 4. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
    J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The technological imperative and the battle for the hearts of America.
    Gillick MR
    Perspect Biol Med; 2007; 50(2):276-94. PubMed ID: 17468543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist devices as alternative to heart transplant. When will they replace allogenic heart transplants?
    Busund R
    Scand Cardiovasc J; 2002 Dec; 36(6):323-6. PubMed ID: 12626196
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanical devices and US Food and Drug Administration (FDA) approval.
    Reitz BA
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2006; ():123-7. PubMed ID: 16638557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future devices and directions.
    Clark RE; Zafirelis Z
    Prog Cardiovasc Dis; 2000; 43(1):95-100. PubMed ID: 10935561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A space age vision advances in the clinic.
    Marshall E
    Science; 2002 Feb; 295(5557):1000-1. PubMed ID: 11834810
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovation with experience using implantable left ventricular assist devices.
    Ascheim DD; Gelijns AC; Rose EA
    Circ Heart Fail; 2009 Jan; 2(1):1-2. PubMed ID: 19808308
    [No Abstract]   [Full Text] [Related]  

  • 12. Costs associated with ventricular assist device use in children.
    Mahle WT; Ianucci G; Vincent RN; Kanter KR
    Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Economic aspects of implementation of the mechanical heart, "HeartMate"].
    Kolbye A; Sander Jensen KM; Aldershvile J; Hansen PB; Kjersem AM; Nielsen KS; Olsen PS; Rasmussen B; Vogelsang G
    Ugeskr Laeger; 2000 Jun; 162(26):3722-5. PubMed ID: 10925632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of the total artificial heart.
    Gray NA; Selzman CH
    Am Heart J; 2006 Jul; 152(1):4-10. PubMed ID: 16824826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REMATCH and beyond: the cost of treating heart failure using an implantable left ventricular assist device.
    Dembitsky WP
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):253-5. PubMed ID: 16959761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destination therapy: does progress depend on left ventricular assist device development?
    von Bayern MP; Cadeiras M; Deng MC
    Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device: can Canada afford this?
    Carrier M
    Can J Cardiol; 2005 Nov; 21(13):1166-8. PubMed ID: 16308591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left-ventricular assist devices as destination therapy for end-stage heart failure.
    TEC Bull (Online); 2002 Nov; 19(3):28-30. PubMed ID: 12839024
    [No Abstract]   [Full Text] [Related]  

  • 20. Heart transplant and left ventricular assist device costs.
    Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.